|
1
|
Rakić M, Patrlj L, Kopljar M, Kliček R,
Kolovrat M, Loncar B and Busic Z: Gallbladder cancer. Hepatobiliary
Surg Nutr. 3:221–226. 2014.
|
|
2
|
Sharma A, Sharma KL, Gupta A, Yadav A and
Kumar A: Gallbladder cancer epidemiology, pathogenesis and
molecular genetics: Recent update. World J Gastroenterol.
23:3978–3998. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI
|
|
4
|
Farr RJ, Joglekar MV and Hardikar AA:
Circulating microRNAs in diabetes progression: Discovery,
validation, and research translation. Exp Suppl. 106:215–244.
2015.PubMed/NCBI
|
|
5
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Acunzo M and Croce CM: MicroRNA in cancer
and cachexia-A mini-review. J Infect Dis. 212 (Suppl 1):S74–S77.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie Y, Li F, Li Z and Shi Z: miR-135a
suppresses migration of gastric cancer cells by targeting
TRAF5-mediated NF-κB activation. Onco Targets Ther. 12:975–984.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu B, Lu X, Zhao Y, Liu C, Huang X, Chen
S, Zhu W, Zhang L and Chen M: MicroRNA-135a induces prostate cancer
cell apoptosis via inhibition of STAT6. Oncol Lett. 17:1889–1895.
2019.PubMed/NCBI
|
|
9
|
Shi HZ, Wang DN, Xu F, Teng JH and Wang
YL: miR-135a inhibits glioma cell proliferation and invasion by
directly targeting FOXO1. Eur Rev Med Pharmacol Sci. 22:4215–4223.
2018.PubMed/NCBI
|
|
10
|
Lv YP, Shi W, Liu HX, Kong XJ and Dai DL:
Identification of miR-146b-5p in tissues as a novel biomarker for
prognosis of gallbladder carcinoma. Eur Rev Med Pharmacol Sci.
21:518–522. 2017.PubMed/NCBI
|
|
11
|
Peng HH, Zhang YD, Gong LS, Liu WD and
Zhang Y: Increased expression of microRNA-335 predicts a favorable
prognosis in primary gallbladder carcinoma. Onco Targets Ther.
6:1625–1630. 2013.PubMed/NCBI
|
|
12
|
Bao RF, Shu YJ, Hu YP, Wang XA, Zhang F,
Liang HB, Ye YY, Li HF, Xiang SS, Weng H, et al: miR-101 targeting
ZFX suppresses tumor proliferation and metastasis by regulating the
MAPK/Erk and Smad pathways in gallbladder carcinoma. Oncotarget.
7:22339–22354. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou H, Guo W, Zhao Y, Wang Y, Zha R, Ding
J, Liang L, Yang G, Chen Z, Ma B and Yin B: MicroRNA-135a acts as a
putative tumor suppressor by directly targeting very low density
lipoprotein receptor in human gallbladder cancer. Cancer Sci.
105:956–965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang G and Yin B: Therapeutic effects of
long-circulating miR-135a-containing cationic immunoliposomes
against gallbladder carcinoma. Sci Rep. 7:59822017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fiedler U and Augustin HG: Angiopoietins:
A link between angiogenesis and inflammation. Trends Immunol.
27:552–558. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang H, Bhat A, Woodnutt G and Lappe R:
Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer.
10:575–585. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Z, Zhu S, Hong J, Soutto M, Peng D,
Belkhiri A, Xu Z and El-Rifai W: Gastric tumour-derived ANGPT2
regulation by DARPP-32 promotes angiogenesis. Gut. 65:925–934.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jary M, Vernerey D, Lecomte T, Dobi E,
Ghiringhelli F, Monnien F, Godet Y, Kim S, Bouché O, Fratte S, et
al: Prognostic value of angiopoietin-2 for death risk
stratification in patients with metastatic colorectal carcinoma.
Cancer Epidemiol Biomarkers Prev. 24:603–612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dreikhausen L, Blank S, Sisic L, Heger U,
Weichert W, Jäger D, Bruckner T, Giese N, Grenacher L, Falk C, et
al: Association of angiogenic factors with prognosis in esophageal
cancer. BMC Cancer. 15:1212015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen J, Yu Y, Chen X, He Y, Hu Q, Li H,
Han Q, Ren F, Li J, Li C, et al: MiR-139-5p is associated with poor
prognosis and regulates glycolysis by repressing PKM2 in
gallbladder carcinoma. Cell Prolif. 51:e125102018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun S, Wang R, Yi S, Li S, Wang L and Wang
J: Roles of the microRNA3383p/NOVA1 axis in retinoblastoma. Mol Med
Rep. 23:3942021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma Y, Ma L, Guo Q and Zhang S: Expression
of bone morphogenetic protein-2 and its receptors in epithelial
ovarian cancer and their influence on the prognosis of ovarian
cancer patients. J Exp Clin Cancer Res. 29:852010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma DJ, Cao Z, Wang BS and Sun YL: Effect
of silencing hepatocyte growth factor receptor c-Met expression on
biological characteristics of colon cancer cells. Zhonghua Zhong
Liu Za Zhi. 42:362–368. 2020.(In Chinese). PubMed/NCBI
|
|
25
|
Liu Y, Fu X, Wang X, Liu Y and Song X:
Long non-coding RNA OIP5-AS1 facilitates the progression of ovarian
cancer via the miR-128-3p/CCNG1 axis. Mol Med Rep. 23:3882021.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Anaya J: OncoLnc: Linking TCGA survival
data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput Sci. 2:e672016.
View Article : Google Scholar
|
|
27
|
Rebane A and Akdis CA: MicroRNAs in
allergy and asthma. Curr Allergy Asthma Rep. 14:4242014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao Z, Qiu J, Yang G, Liu Y, Luo W, You L,
Zheng L and Zhang T: MiR-135a biogenesis and regulation in
malignancy: A new hope for cancer research and therapy. Cancer Biol
Med. 17:569–582. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang C, Zheng X, Ye K, Sun Y, Lu Y, Fan Q
and Ge H: miR-135a inhibits the invasion and migration of
esophageal cancer stem cells through the hedgehog signaling pathway
by targeting Smo. Mol Ther Nucleic Acids. 19:841–852. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi H, Ji Y, Zhang D, Liu Y and Fang P:
MiR-135a inhibits migration and invasion and regulates EMT-related
marker genes by targeting KLF8 in lung cancer cells. Biochem
Biophys Res Commun. 465:125–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen Y, Zhang J, Wang H, Zhao J, Xu C, Du
Y, Luo X, Zheng F, Liu R, Zhang H and Ma D: miRNA-135a promotes
breast cancer cell migration and invasion by targeting HOXA10. BMC
Cancer. 12:1112012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mao XP, Zhang LS, Huang B, Zhou SY, Liao
J, Chen LW, Qiu SP and Chen JX: Mir-135a enhances cellular
proliferation through post-transcriptionally regulating PHLPP2 and
FOXO1 in human bladder cancer. J Transl Med. 13:862015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ren JW, Li ZJ and Tu C: MiR-135
post-transcriptionally regulates FOXO1 expression and promotes cell
proliferation in human malignant melanoma cells. Int J Clin Exp
Pathol. 8:6356–6366. 2015.PubMed/NCBI
|
|
34
|
Nagel R, le Sage C, Diosdado B, van der
Waal M, Oude Vrielink JA, Bolijn A, Meijer GA and Agami R:
Regulation of the adenomatous polyposis coli gene by the miR-135
family in colorectal cancer. Cancer Res. 68:5795–5802. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fukagawa S, Miyata K, Yotsumoto F,
Kiyoshima C, Nam SO, Anan H, Katsuda T, Miyahara D, Murata M, Yagi
H, et al: MicroRNA-135a-3p as a promising biomarker and nucleic
acid therapeutic agent for ovarian cancer. Cancer Sci. 108:886–896.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu B, Tao T, Wang Y, Fang F, Huang Y, Chen
S, Zhu W and Chen M: hsa-miR-135a-1 inhibits prostate cancer cell
growth and migration by targeting EGFR. Tumour Biol.
37:14141–14151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tang Y, Cao G, Zhao G, Wang C and Qin Q:
LncRNA differentiation antagonizing non-protein coding RNA promotes
proliferation and invasion through regulating miR-135a/NLRP37 axis
in pancreatic cancer. Invest New Drugs. 38:714–721. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rakoczy PE, Brankov M, Fonceca A, Zaknich
T, Rae BC and Lai CM: Enhanced recombinant adeno-associated
virus-mediated vascular endothelial growth factor expression in the
adult mouse retina: A potential model for diabetic retinopathy.
Diabetes. 52:857–863. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
39:10104283177146262017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rigamonti N, Kadioglu E, Keklikoglou I,
Wyser Rmili C, Leow CC and De Palma M: Role of angiopoietin-2 in
adaptive tumor resistance to VEGF signaling blockade. Cell Rep.
8:696–706. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu Y, Zhang Y, Wang Z, Chen N, Zhou J and
Liu L: The role of serum angiopoietin-2 levels in progression and
prognosis of lung cancer: A meta-analysis. Medicine (Baltimore).
96:e80632017. View Article : Google Scholar : PubMed/NCBI
|
